Despite the potential benefits of cloud technology for the life sciences and pharmaceutical industry, there are still barriers to adoption. One challenge is the resistance from executives who believe sensitive data cannot be safely stored in the cloud. Local laws that prohibit data access by non-healthcare professionals and misleading claims by cloud vendors also pose challenges. The control over data storage and concerns about security compliance are additional obstacles for pharma’s transition to the cloud. Expert guidance and understanding the implications are crucial for a secure move to the cloud.
Lazarus Group’s Cryptocurrency Holdings Plummet to $47 Million Amid Heightened Cybersecurity Concerns
North Korea’s Lazarus Group’s cryptocurrency holdings have dwindled to $47m, with most of their digital wealth held in Bitcoin. Their stash has significantly decreased from
